HPB & Spleen · 28 December 2025

Disparities Impact Pancreatic Cancer Outcomes

Multimodal treatment disparities in pancreatic cancer significantly affect patient survival and care.

8,466 patients analyzed; nonmetastatic cases had higher therapy rates than metastatic.
Non-Hispanic black patients experienced longer delays to treatment compared to non-Hispanic whites.
Uninsured and Medicaid patients showed the highest odds of not receiving therapy in metastatic cases.

Primary resection strongly predicts improved survival outcomes. Addressing these disparities is critical for enhancing patient care strategies.

Journal Article by Galatas A, Malinosky HR (…) Moaven O et 7 al. in J Surg Oncol

read the whole article in J Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

The latest stitches

Ann Surg Oncol2 Nov 2026

Pancreatic ductoscopy guides tissue preservation

In two older patients having robotic surgery for a pancreatic growth, ductoscopy and checks of the cut edge let surgeons leave the remaining pancreas in place.

HPB & Spleen30 Oct 2026

Intrahepatic cholangiocarcinoma has more options

Resection remains central, but care now includes preoperative therapy, liver-directed treatments and drugs matched to tumor changes.

Ann Surg Oncol29 Oct 2026

Pancreatic cancer: longer survival with combined treatment

For locally advanced pancreatic cancer, cryoablation plus drug treatment was linked to longer median survival than drug treatment alone, but the result does not prove benefit.

All papers in HPB & Spleen →